Induction of an EMT-like transformation and MET in vitro

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Ding, Songming ^a,b   Zhang, Wu ^a,b   Xu, Zhiyuan ^a,b   Xing, Chunyang ^a,b   Xie, Haiyang ^a,b   Guo, Haijun ^a,b   Chen, Kanjie ^a,b   Song, Penghong ^a,b   Gu, Yu ^a   Xiao, Fengqiang ^a,b   Zhou, Lin ^a,b   Zheng, Shusen ^a,b  

^a BEIJING HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Co culture; Conditioned medium culture; EMT; MET; Tumor microenvironment

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BETA1 INTEGRIN; BETA4 INTEGRIN; CYTOKERATIN 19; UVOMORULIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL ELONGATION; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CELL VIABILITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MESENCHYMAL TO EPITHELIAL TRANSITION; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; LAMININ; LIVER NEOPLASMS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECURRENCE;

EID: 84879808294     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-164     Document Type: Article

References (40)

1. Lorusso G, Rüegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 2008, 130:1091-1103. 10.1007/s00418-008-0530-8, 18987874.
2. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2008, 9:239-252. 10.1038/nrg2317, 3251309, 19279573.
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545. 10.1016/S0140-6736(00)04046-0, 11229684.
4. Wei WZ, Fulton A, Winkelhake J, Heppner G. Correlation of Natural Killer Activity with Tumorigenesis of a Preneoplastic Mouse Mammary Lesion. Cancer Res 1989, 49:2709-2715.
5. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999, 13:1382-1397. 10.1101/gad.13.11.1382, 316772, 10364156.
6. Vincent-Salomon A, Thiery JP. Host microenvironment in breast cancer development Epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 2003, 5:101-106. 10.1186/bcr578, 154156, 12631389.
7. Jou J, Diehl AM. Epithelial-mesenchymal transitions and hepatocarcinogenesis. J Clin Invest 2010, 120:1031-1034. 10.1172/JCI42615, 2846072, 20335655.
8. Yang J, Mani SA, Weinberg RA. Exploring a New Twist on Tumor Metastasis. Cancer Res 2006, 66:4549-4552. 10.1158/0008-5472.CAN-05-3850, 16651402.
9. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601. 10.1038/ncb1722, 18376396.
10. Katoh M. Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 2005, 27:1677-1683.
11. Bates RC, Mercurio AM. The Epithelial-Mesenchymal Transition (EMT) and Colorectal Cancer Progression. Cancer Biol Ther 2005, 4:365-370. 10.4161/cbt.4.4.1655, 15846061.
12. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981. 10.1083/jcb.200601018, 2063755, 16567498.
13. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
14. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383. 10.1002/jcp.21223, 17680632.
15. Spaderna S, Schmalhofer O, Hlubek F, Jung A, Kirchner T, Brabletz T. Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh Dtsch Ges Pathol 2007, 91:21-28.
16. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2. Cancer Res 2006, 66:11271-11278. 10.1158/0008-5472.CAN-06-2044, 17145872.
17. Fitzgerald MP, Gourronc F, Teoh ML, Provenzano MJ, Case AJ, Martin JA, Domann FE. Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition During Sarcomagenesis. Sarcoma 2011, 2011:598218. 3087947, 21559267.
18. Peter ME. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852. 10.4161/cc.8.6.7907, 2688687, 19221491.
19. Naoko T, Warren RQ, Percy Ivy S. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 2011, 13(3):211-222. 10.1186/bcr2876, 3218933, 21672282.
20. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005, 129:1375-1383. 10.1053/j.gastro.2005.09.055, 16285938.
21. Gupta SK, Oommen S, Aubry MC, Williams BP, Vlahakis NE. Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene 2013, 32(2):141-150. 10.1038/onc.2012.41, 3368989, 22370635.
22. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002, 12:89-96. 10.1006/scbi.2001.0416, 12027580.
23. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T. Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and beta-Catenin. Cells Tissues Organs 2005, 179:56-65. 10.1159/000084509, 15942193.
24. Lundgren K, Nordenskjöld B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009, 101:1769-1781. 10.1038/sj.bjc.6605369, 2778529, 19844232.
25. Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, Yang C. Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci 2011, 121(1):110-122. 10.1093/toxsci/kfr029, 3080188, 21292642.
26. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746. 10.1016/j.ceb.2003.10.006, 14644200.
27. Scheel C, Onder T, Karnoub A, Weinberg R. Adaptation versus selection: the origins of metastatic behavior. Cancer Res 2007, 67:11476-11479. 10.1158/0008-5472.CAN-07-1653, 18089773.
28. Huber M, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558. 10.1016/j.ceb.2005.08.001, 16098727.
29. Tao YS, Ma XY, Chai DM, Ma L, Feng ZZ, Cheng ZN, Lai MD. Overexpression of MMP-1 and VEGF-C is Associated with a Less Favorable Prognosis in Esophageal Squamous Cell Carcinoma. Onkologie 2012, 35:651-656. 10.1159/000343637, 23147541.
30. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010, 70:7640-7651. 10.1158/0008-5472.CAN-10-0824, 20876809.
31. Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, Huang W, Li Y, Cui HY, Guo YS, Tavernier J, Zhang SH, Jiang JL, Chen ZN. HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatolog 2011, 54:2012-2024.
32. Li SH, Fu J, Watkins DN, Srivastava RK, Shankar S. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol Cell Biochem 2012, 373:217-227.
33. Parr C, Jiang WG. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 2001, 19:857-863.
34. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
35. Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 2013, 92(2):114-121. 10.1177/0022034512467352, 23128109.
36. Santos PB, Zanetti JS, Silva AR, Beltrão EIC. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study. Diagn Pathol 2012, 7:104. 10.1186/1746-1596-7-104, 3523034, 22894137.
37. Dingemans AM, van den Boogaart V, Vosse BA, van Suylen RJ, Griffioen AW, Thijssen VL. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer. Mol Cancer 2010, 9(152):1-9. 2818691, 20051109.
38. Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1- integrins in invasive breast cancer. J Pathol 1999, 187(5):523-529. 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3, 10398116.
39. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007, 67(2):659-664. 10.1158/0008-5472.CAN-06-2768, 17234776.
40. Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma. J Gastrointest Surg 2011, 15(2):321-329. 10.1007/s11605-010-1373-x, 21061181.